Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers - Trial NCT00225667
Access comprehensive clinical trial information for NCT00225667 through Pure Global AI's free database. This Phase 3 trial is sponsored by Connolly, Stuart, M.D. and is currently status unknown. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Connolly, Stuart, M.D.
Timeline & Enrollment
Phase 3
Dec 01, 2005
Jul 01, 2007
Primary Outcome
Time to recurrent AHRE ( 220/min for 2 minutes)
Summary
The purpose of this study is to determine whether irbesartan will reduce the rate of
 recurrent atrial high rate episodes and the development of clinical sustained atrial
 fibrillation in patients with hypertension and permanent pacemaker.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT00225667
Non-Device Trial